November 18, 2019
Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent Director
~ The Company Remains Focused on Completing the LOGICS Study and Submitting a New Drug Application (NDA) for RECORLEV™ (levoketoconazole), While Ensuring Continued Growth and Pro...
Read more
Read more
November 13, 2019
Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
Oslo, Norway, 13 November 2019
Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the third quarter 2019 on Tuesday, 19 November...
Read more
Read more
November 13, 2019
Vicore Pharma has completed a directed share issue of approximately SEK 125 million
2019-11-13
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, THE UNITED KINGDOM, CANADA, HONGKONG, JAPAN, SWITZERLAND, NEW ZEALAND, S...
Read more
Read more
November 12, 2019
BONESUPPORT appoints Fergus MacLeod as General Manager and Executive Vice President Commercial Operations EUROW
Lund, Sweden, 16:00 CET, November 12 2019BONESUPPORT™ an emerging leader in orthobiologics for the management of bone injuries, announces changes in its leadership team that will...
Read more
Read more
November 12, 2019
Strongbridge Biopharma plc to Present at Two Upcoming Investor Conferences
DUBLIN, Ireland and TREVOSE, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company foc...
Read more
Read more
November 11, 2019
Presentation of ONCOS-102 melanoma data at SITC Annual Meeting
Oslo, Norway, 11 November 2019 – Targovax ASA (OSE: TRVX), announces that clinical data from its combination trial with ONCOS-102 and Keytruda in anti-PD1 refractory melanoma...
Read more
Read more
November 11, 2019
GOLD’s evidence “A” rating affirms that endobronchial valves, like the Zephyr Valve, are a proven, viable, minimally-invasive treatment option for severe emphysema, a form of COPD
REDWOOD CITY, California, November 11, 2019 – Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that the 2020 update from the Global I...
Read more
Read more
November 8, 2019
Orexo to Present at Jefferies 2019 Healthcare Conference
Uppsala, Sweden – November 8, 2019 - Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the comp...
Read more
Read more
November 8, 2019
Interim report January-September 2019
Gothenburg, November 8, 2019 - Vicore Pharma Holding AB (publ) publish the interim report for the third quarter 2019.
Important events during the third quarter
· In S...
Read more
Read more
November 7, 2019
Strongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate Update
~ KEVEYIS® (dichlorphenamide) Achieved $5.7 Million in Revenue Along with a Positive Contribution Margin in Third Quarter of 2019; Strongbridge Remains On-Track to Mee...
Read more
Read more